Two kinetically-distinct components of UDP-glucuronic acid transport in rat liver endoplasmic reticulum. 1996

E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock 72204, USA.

Previous studies have documented the presence of protein-mediated transport of UDP-glucuronic acid (UDP-GlcUA) in rat liver endoplasmic reticulum (ER). Measurement of uptake at varying concentrations of high specific activity [beta-32P]UDP-GlcUA has revealed the presence of a two component UDP-GlcUA transporting system. Transport at low substrate concentrations occurred predominantly via a high affinity component (K(m) = 1.6 microM), whereas a low affinity component (K(m) = 38 microM) predominated at high substrate concentrations. The K(m) for the high affinity system is in agreement with that previously published, while the low affinity component is a new finding. The uptake of UDP-GlcUA was temperature-sensitive, time dependent, and saturable for both components. The high affinity transport was affected by trans-stimulation and cis-inhibition by UDP-N-acetylglucosamine (UDP-GlcNAc); however, the same concentrations of UDP-GlcNAc had less effect on the low affinity system. In order to further study the two transport components, various inhibitors of anion transport carriers were tested. The high affinity component was strongly inhibited by 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid (SITS) and furosemide, while the low affinity system was less sensitive to these reagents. Dose-dependent inhibition by 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) was found for both transport systems. Probenecid was found to be a weak inhibitor of both components of the UDP-GlcUA uptake. Finally, the major metabolite of 3'-azido-3'-deoxythymidine, 3'-azido-3'-deoxythymidine monophosphate (AZTMP), was able to inhibit the uptake of UDP-GlcUA by both components. The results indicate the presence of two carrier-mediated UDP-glucuronic acid transporting components in rat liver ER.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004721 Endoplasmic Reticulum A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed) Ergastoplasm,Reticulum, Endoplasmic
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic

Related Publications

E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
August 1994, The Biochemical journal,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
January 1998, Biochemistry,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
April 1996, The Biochemical journal,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
October 1994, Biochimica et biophysica acta,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
January 1983, Drug metabolism and disposition: the biological fate of chemicals,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
May 1997, The Biochemical journal,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
January 1970, Zeitschrift fur Kinderheilkunde,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
February 1981, FEBS letters,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
September 1993, The Journal of physiology,
E Battaglia, and S Nowell, and R R Drake, and M Mizeracka, and C L Berg, and J Magdalou, and S Fournel-Gigleux, and J L Gollan, and R Lester, and A Radominska
April 1996, The Biochemical journal,
Copied contents to your clipboard!